PAVmed (PAVM) Acquisitions (2021 - 2022)
PAVmed's (PAVM) quarterly Acquisitions came in at $1.0 million in Q3 2022, up 900.0% year-on-year from $100000.0 in Q3 2021, and down 52.38% quarter-over-quarter from $2.1 million in Q4 2021.
PAVmed (PAVM) Acquisitions (2021 - 2022) Analysis & Trends
PAVmed's Acquisitions history runs 2 years deep, the most recent figure standing at $1.0 million for Q3 2022.
- On a quarterly basis, Acquisitions rose 900.0% year-over-year to $1.0 million in Q3 2022; TTM through Dec 2022 was $3.2 million, a N/A change from a year earlier, with the FY2022 full-year figure at $3.2 million, up 42.41% from the prior year.
- Acquisitions declined to $1.0 million in Q3 2022 per PAVM's latest filing, from $2.1 million in the prior quarter.
- Across five years, Acquisitions topped out at $2.1 million in Q4 2021 and bottomed at $100000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.17 Bn | 175.87 Bn | 6.27 Bn | - |
| 2 | Stryker | 129.06 Bn | 126.18 Bn | 3.81 Bn | 22.00 Mn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 406.00 Mn |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | 523.00 Mn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.08 Bn | 25.80 Bn | 1.98 Bn | 2.30 Bn |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | -268.10 Mn |
| 10 | PAVmed | 11.15 Mn | 9.62 Mn | -4,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1.00 Mn |
| Dec 31, 2021 | 2.10 Mn |
| Sep 30, 2021 | 100,000.00 |